Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74b7b50944d8e1960440fb1f5440b7fd |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-626 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-347 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-8146 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70503 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70539 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4716 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-974 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-5412 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-7452 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-226 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-8139 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-5434 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-7151 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-5421 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-522 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
2014-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4813e205bf4f9a9f91a3638e9a8bf41a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da0e7c61cb5ec22d87b8200c3cd48673 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56a98ddc148deabdfa0f2111bd94b28e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f954101c98ac6f773602c520cfed6d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5c2b7ee8808d8218bd9a4855bf4447b |
publicationDate |
2018-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20180026555-A |
titleOfInvention |
Atypical hemolytic uremic syndrome (ahus) biomarker proteins |
abstract |
The present invention provides a biomarker protein whose alteration of its concentration or activity level is associated with clinically significant treatment of aHUS using atypical hemolytic uremic syndrome (aHUS) or complement inhibitors. Compositions and methods for examining the concentration and / or activity of one or more biomarker proteins in a biological fluid are also provided. The compositions and methods are particularly useful for evaluating the risk of aHUS and / or for diagnosing aHUS and / or for determining whether the subject is experiencing the first acute manifestation of aHUS and / or monitoring progression or alleviation of aHUS and / Are useful for monitoring the response to treatment with an inhibitor or for optimizing such treatment. |
priorityDate |
2013-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |